CN1660408A - Medicine to be taken after being mixed in liquor of possessing bearutified and-faced effects - Google Patents
Medicine to be taken after being mixed in liquor of possessing bearutified and-faced effects Download PDFInfo
- Publication number
- CN1660408A CN1660408A CN 200410104430 CN200410104430A CN1660408A CN 1660408 A CN1660408 A CN 1660408A CN 200410104430 CN200410104430 CN 200410104430 CN 200410104430 A CN200410104430 A CN 200410104430A CN 1660408 A CN1660408 A CN 1660408A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- fructus
- electuary
- mannatide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 74
- 230000000694 effects Effects 0.000 title claims abstract description 51
- 229940079593 drug Drugs 0.000 title description 11
- 241000628997 Flos Species 0.000 claims description 41
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 34
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 33
- 235000008434 ginseng Nutrition 0.000 claims description 33
- 210000000582 semen Anatomy 0.000 claims description 31
- FINHMKGKINIASC-UHFFFAOYSA-N Tetramethylpyrazine Chemical compound CC1=NC(C)=C(C)N=C1C FINHMKGKINIASC-UHFFFAOYSA-N 0.000 claims description 24
- 241000190633 Cordyceps Species 0.000 claims description 18
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical group O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 claims description 18
- 241000222336 Ganoderma Species 0.000 claims description 16
- 239000008280 blood Substances 0.000 claims description 14
- 241000218628 Ginkgo Species 0.000 claims description 13
- 235000011201 Ginkgo Nutrition 0.000 claims description 13
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 13
- 244000269722 Thea sinensis Species 0.000 claims description 13
- 210000004369 blood Anatomy 0.000 claims description 13
- 235000009569 green tea Nutrition 0.000 claims description 13
- 230000002503 metabolic effect Effects 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 11
- 241001116389 Aloe Species 0.000 claims description 10
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 10
- 235000011399 aloe vera Nutrition 0.000 claims description 10
- 230000003647 oxidation Effects 0.000 claims description 10
- 238000007254 oxidation reaction Methods 0.000 claims description 10
- 239000009636 Huang Qi Substances 0.000 claims description 8
- 210000004185 liver Anatomy 0.000 claims description 8
- 244000293323 Cosmos caudatus Species 0.000 claims description 7
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 7
- 241000180649 Panax notoginseng Species 0.000 claims description 7
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 7
- 210000003734 kidney Anatomy 0.000 claims description 7
- 230000002087 whitening effect Effects 0.000 claims description 7
- 241000756943 Codonopsis Species 0.000 claims description 5
- 108010052008 colla corii asini Proteins 0.000 claims description 5
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 241000208340 Araliaceae Species 0.000 claims 10
- 229920001231 Polysaccharide peptide Polymers 0.000 claims 1
- 108010022457 polysaccharide peptide Proteins 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 21
- 238000002360 preparation method Methods 0.000 abstract description 18
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 9
- 229920000057 Mannan Polymers 0.000 abstract description 8
- 230000001105 regulatory effect Effects 0.000 abstract description 8
- 239000007924 injection Substances 0.000 abstract description 7
- 238000002347 injection Methods 0.000 abstract description 7
- 230000032683 aging Effects 0.000 abstract description 6
- 230000005764 inhibitory process Effects 0.000 abstract description 5
- 230000004060 metabolic process Effects 0.000 abstract description 5
- 210000001835 viscera Anatomy 0.000 abstract description 5
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 4
- 230000007368 endocrine function Effects 0.000 abstract description 2
- 230000007102 metabolic function Effects 0.000 abstract description 2
- 239000003963 antioxidant agent Substances 0.000 abstract 2
- 230000003078 antioxidant effect Effects 0.000 abstract 2
- 230000002000 scavenging effect Effects 0.000 abstract 2
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 230000003750 conditioning effect Effects 0.000 abstract 1
- 230000001934 delay Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 36
- 240000005373 Panax quinquefolius Species 0.000 description 24
- 210000002752 melanocyte Anatomy 0.000 description 23
- 239000008187 granular material Substances 0.000 description 21
- 238000000034 method Methods 0.000 description 21
- 239000000047 product Substances 0.000 description 20
- 238000012360 testing method Methods 0.000 description 20
- 241001494479 Pecora Species 0.000 description 19
- 210000003491 skin Anatomy 0.000 description 19
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 210000003743 erythrocyte Anatomy 0.000 description 17
- 238000000855 fermentation Methods 0.000 description 16
- 230000004151 fermentation Effects 0.000 description 15
- 108010010998 polyactin A Proteins 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 230000001580 bacterial effect Effects 0.000 description 14
- 239000008363 phosphate buffer Substances 0.000 description 14
- 239000013558 reference substance Substances 0.000 description 14
- 230000000295 complement effect Effects 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- 239000000463 material Substances 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 9
- 206010018910 Haemolysis Diseases 0.000 description 9
- 229930003268 Vitamin C Natural products 0.000 description 9
- 230000008588 hemolysis Effects 0.000 description 9
- 235000019154 vitamin C Nutrition 0.000 description 9
- 239000011718 vitamin C Substances 0.000 description 9
- 239000000427 antigen Substances 0.000 description 8
- 108091007433 antigens Proteins 0.000 description 8
- 102000036639 antigens Human genes 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 238000010790 dilution Methods 0.000 description 7
- 239000012895 dilution Substances 0.000 description 7
- 238000000338 in vitro Methods 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 206010070834 Sensitisation Diseases 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 102000003425 Tyrosinase Human genes 0.000 description 6
- 108060008724 Tyrosinase Proteins 0.000 description 6
- 229960004756 ethanol Drugs 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- 230000005847 immunogenicity Effects 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 6
- 230000008313 sensitization Effects 0.000 description 6
- 230000009849 deactivation Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 238000011218 seed culture Methods 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 108010006464 Hemolysin Proteins Proteins 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 4
- 241000194017 Streptococcus Species 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 238000010241 blood sampling Methods 0.000 description 4
- 238000005660 chlorination reaction Methods 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 230000001815 facial effect Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000003228 hemolysin Substances 0.000 description 4
- 238000009413 insulation Methods 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000008354 sodium chloride injection Substances 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 241000700199 Cavia porcellus Species 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 208000012641 Pigmentation disease Diseases 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000012531 culture fluid Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000002054 inoculum Substances 0.000 description 3
- 229960004502 levodopa Drugs 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 230000019612 pigmentation Effects 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000001117 sulphuric acid Substances 0.000 description 3
- 235000011149 sulphuric acid Nutrition 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 2
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 101001057156 Homo sapiens Melanoma-associated antigen C2 Proteins 0.000 description 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- 102100027252 Melanoma-associated antigen C2 Human genes 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 244000061458 Solanum melongena Species 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000005842 biochemical reaction Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- JJWKPURADFRFRB-UHFFFAOYSA-N carbonyl sulfide Chemical compound O=C=S JJWKPURADFRFRB-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 230000005486 microgravity Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 238000011020 pilot scale process Methods 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 238000003906 pulsed field gel electrophoresis Methods 0.000 description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 2
- 235000010262 sodium metabisulphite Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 description 1
- QGZCUOLOTMJILH-UHFFFAOYSA-N 2h-tetrazol-2-ium;bromide Chemical compound [Br-].C1=N[NH+]=NN1 QGZCUOLOTMJILH-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 208000012239 Developmental disease Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 244000182067 Fraxinus ornus Species 0.000 description 1
- 235000002917 Fraxinus ornus Nutrition 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- 208000021710 Hyperpigmentation disease Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 206010027145 Melanocytic naevus Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 208000007256 Nevus Diseases 0.000 description 1
- 241000283898 Ovis Species 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- NUQJULCGNZMBEF-UHFFFAOYSA-N Prostratin Natural products COC(=O)C12CC(C)C3(O)C(C=C(CO)CC4(O)C3C=C(C)C4=O)C1C2(C)C NUQJULCGNZMBEF-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000594182 Sarcophaga sigma Species 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 239000012490 blank solution Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000008576 chronic process Effects 0.000 description 1
- 239000003034 coal gas Substances 0.000 description 1
- 239000011280 coal tar Substances 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 230000005782 double-strand break Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000009605 growth rhythm Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000003814 hair luster Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 102000057593 human F8 Human genes 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 235000014666 liquid concentrate Nutrition 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000029052 metamorphosis Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 229940127234 oral contraceptive Drugs 0.000 description 1
- 239000003539 oral contraceptive agent Substances 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 229940047431 recombinate Drugs 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 231100000456 subacute toxicity Toxicity 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Group 10 5/ml) | Drug level | Cell number (* |
Blank group first kind of electuary group second electuary of the present invention group the third electuary group of the present invention the 4th kind of electuary group of the present invention the 5th kind of electuary group α of the present invention-mannatide group vitamin C group of the present invention | ????—— ????????0.1g/L ????0.1g/L ????0.1g/L ????0.1g/L ????0.1g/L ????0.1mg/L ????0.5g/L | ????4.2 ????2.32* ????2.07* ????1.7** ????1.68** ????1.50** ????3.53 ????3.01 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004101044304A CN100350969C (en) | 2003-12-31 | 2004-12-19 | Medicine to be taken after being mixed in liquor of possessing bearutified and-faced effects |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200310122259.5 | 2003-12-31 | ||
CN200310122259 | 2003-12-31 | ||
CNB2004101044304A CN100350969C (en) | 2003-12-31 | 2004-12-19 | Medicine to be taken after being mixed in liquor of possessing bearutified and-faced effects |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1660408A true CN1660408A (en) | 2005-08-31 |
CN100350969C CN100350969C (en) | 2007-11-28 |
Family
ID=35010145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004101044304A Expired - Fee Related CN100350969C (en) | 2003-12-31 | 2004-12-19 | Medicine to be taken after being mixed in liquor of possessing bearutified and-faced effects |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100350969C (en) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101032599B (en) * | 2007-04-10 | 2010-04-21 | 尹凤琴 | Healthy solution for conditioning skin and losing weight |
CN102366478A (en) * | 2011-11-14 | 2012-03-07 | 四川逢春制药有限公司 | Composition for whitening skin and resisting senescence, preparation method and application thereof |
CN101861960B (en) * | 2010-01-21 | 2012-05-30 | 海南京润珍珠生物技术股份有限公司 | Pearl freckle dispelling aesthetic health care food |
CN102640920A (en) * | 2012-04-23 | 2012-08-22 | 北京绿源求证科技发展有限责任公司 | Dietary cosmetic tea granules |
CN103127395A (en) * | 2013-03-19 | 2013-06-05 | 云南云尚生物技术有限公司 | Dendrobe anti-oxidation preparation and preparation method thereof |
CN103627611A (en) * | 2013-12-18 | 2014-03-12 | 陈坤鑫 | SOD (Superoxide Dismutase) whitening, speckle reducing, life cultivating and health preserving wine and preparation method thereof |
CN103932018A (en) * | 2014-03-25 | 2014-07-23 | 合肥市金乡味工贸有限责任公司 | Rose beautifying rice flour for steaming meat |
CN103976058A (en) * | 2014-04-25 | 2014-08-13 | 贵州三泓药业股份有限公司 | Radix pseudostellariae green tea beverage |
CN104188038A (en) * | 2014-07-29 | 2014-12-10 | 汤兴华 | Dendrobe electuary with function of beautifying |
CN104473153A (en) * | 2014-11-20 | 2015-04-01 | 青岛恒波仪器有限公司 | Beautifying mulberry oral liquid and preparation method thereof |
CN104490696A (en) * | 2014-12-18 | 2015-04-08 | 祝迈 | Traditional Chinese medicine mask with nourishing and anti-ageing effects |
CN104524335A (en) * | 2014-12-29 | 2015-04-22 | 张解 | Pill for conditioning female endocrine disorders and preparation method of pill |
CN105770078A (en) * | 2016-03-13 | 2016-07-20 | 辽宁泰阳医药科技开发有限公司 | Pharmaceutical composition as well as preparation and application thereof |
CN106387212A (en) * | 2016-08-29 | 2017-02-15 | 天津保元堂生物科技有限公司 | Vitality protection Qianjin tea, as well as preparation method and brewing method thereof |
CN107581605A (en) * | 2017-09-05 | 2018-01-16 | 夏战利 | A kind of healthy product for beautifying face and preparation method thereof |
CN108853354A (en) * | 2018-08-07 | 2018-11-23 | 乐清市益寿铁皮石斛专业种植场 | For qi-blood deficiency and beautifying face and moistering lotion composition and preparation method and purposes |
CN109275815A (en) * | 2017-07-19 | 2019-01-29 | 王美锦 | The beverage formulation of health |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1089250C (en) * | 1998-11-27 | 2002-08-21 | 杨延珍 | Anticancer oral liquid contg. lipolytic enzyme |
-
2004
- 2004-12-19 CN CNB2004101044304A patent/CN100350969C/en not_active Expired - Fee Related
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101032599B (en) * | 2007-04-10 | 2010-04-21 | 尹凤琴 | Healthy solution for conditioning skin and losing weight |
CN101861960B (en) * | 2010-01-21 | 2012-05-30 | 海南京润珍珠生物技术股份有限公司 | Pearl freckle dispelling aesthetic health care food |
CN102366478A (en) * | 2011-11-14 | 2012-03-07 | 四川逢春制药有限公司 | Composition for whitening skin and resisting senescence, preparation method and application thereof |
CN102366478B (en) * | 2011-11-14 | 2013-04-03 | 四川逢春制药有限公司 | Composition for whitening skin and resisting senescence, preparation method and application thereof |
CN102640920B (en) * | 2012-04-23 | 2013-06-19 | 北京绿源求证科技发展有限责任公司 | Dietary cosmetic tea granules |
CN102640920A (en) * | 2012-04-23 | 2012-08-22 | 北京绿源求证科技发展有限责任公司 | Dietary cosmetic tea granules |
CN103127395B (en) * | 2013-03-19 | 2015-01-14 | 云南云尚生物技术有限公司 | Dendrobe anti-oxidation preparation and preparation method thereof |
CN103127395A (en) * | 2013-03-19 | 2013-06-05 | 云南云尚生物技术有限公司 | Dendrobe anti-oxidation preparation and preparation method thereof |
CN103627611B (en) * | 2013-12-18 | 2014-09-10 | 陈坤鑫 | SOD (Superoxide Dismutase) whitening, speckle reducing, life cultivating and health preserving wine and preparation method thereof |
CN103627611A (en) * | 2013-12-18 | 2014-03-12 | 陈坤鑫 | SOD (Superoxide Dismutase) whitening, speckle reducing, life cultivating and health preserving wine and preparation method thereof |
CN103932018B (en) * | 2014-03-25 | 2016-01-20 | 合肥市金乡味工贸有限责任公司 | The U.S. face rice flour for steamed meat of a kind of rose |
CN103932018A (en) * | 2014-03-25 | 2014-07-23 | 合肥市金乡味工贸有限责任公司 | Rose beautifying rice flour for steaming meat |
CN103976058A (en) * | 2014-04-25 | 2014-08-13 | 贵州三泓药业股份有限公司 | Radix pseudostellariae green tea beverage |
CN104188038A (en) * | 2014-07-29 | 2014-12-10 | 汤兴华 | Dendrobe electuary with function of beautifying |
CN104473153A (en) * | 2014-11-20 | 2015-04-01 | 青岛恒波仪器有限公司 | Beautifying mulberry oral liquid and preparation method thereof |
CN104490696A (en) * | 2014-12-18 | 2015-04-08 | 祝迈 | Traditional Chinese medicine mask with nourishing and anti-ageing effects |
CN104524335A (en) * | 2014-12-29 | 2015-04-22 | 张解 | Pill for conditioning female endocrine disorders and preparation method of pill |
CN104524335B (en) * | 2014-12-29 | 2019-04-09 | 上海耀大生物科技有限公司 | A kind of pill and preparation method for female endocrine dyscrasia conditioning |
CN105770078A (en) * | 2016-03-13 | 2016-07-20 | 辽宁泰阳医药科技开发有限公司 | Pharmaceutical composition as well as preparation and application thereof |
CN105770078B (en) * | 2016-03-13 | 2020-11-06 | 辽宁泰阳医药科技开发有限公司 | Pharmaceutical composition, preparation and application thereof |
CN106387212A (en) * | 2016-08-29 | 2017-02-15 | 天津保元堂生物科技有限公司 | Vitality protection Qianjin tea, as well as preparation method and brewing method thereof |
CN109275815A (en) * | 2017-07-19 | 2019-01-29 | 王美锦 | The beverage formulation of health |
CN107581605A (en) * | 2017-09-05 | 2018-01-16 | 夏战利 | A kind of healthy product for beautifying face and preparation method thereof |
CN108853354A (en) * | 2018-08-07 | 2018-11-23 | 乐清市益寿铁皮石斛专业种植场 | For qi-blood deficiency and beautifying face and moistering lotion composition and preparation method and purposes |
Also Published As
Publication number | Publication date |
---|---|
CN100350969C (en) | 2007-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100350969C (en) | Medicine to be taken after being mixed in liquor of possessing bearutified and-faced effects | |
CN102078512B (en) | Pharmaceutical composition for improving fatigue and preparation method thereof | |
CN102424625B (en) | Edible and medical fungi blackening agent, its preparation method and application | |
CN1240390C (en) | Biologic converted ginseng composition and preparing process thereof | |
CN108991529B (en) | Food composition for invigorating spleen and nourishing vitality and preparation method thereof | |
CN109528568A (en) | A kind of composition and preparation method thereof with anti-aging and white-skinned face function | |
CN103735825A (en) | Comprehensive conditioning traditional Chinese medicine composition and application thereof | |
CN103405577B (en) | The Pharmaceutical composition of a kind of enhancing immunity, fatigue alleviating | |
WO2010076922A1 (en) | Anticancer health food containing ginseng powder fermented with mushrooms | |
CN103734696B (en) | A kind of soft capsule and preparation method thereof improving immunity, protection internal organs | |
CN103155985B (en) | Rhizoma polygonati nutrition powder and preparation method thereof | |
CN100453063C (en) | Frost-like powder possessing effects of beautification and nourishing face | |
CN113115942A (en) | Blood fat reducing dietary formula and processing technology thereof | |
CN100381167C (en) | Medicine for treating neurasthenia | |
CN106993750A (en) | A kind of instant porridge for recovering patients with chronic colitis gut flora balance and preparation method thereof | |
CN106983821A (en) | A kind of pharmaceutical composition of strengthen immunity and preparation method thereof, preparation and application | |
CN106666703A (en) | Enzyme composition with liver-protecting function, as well as preparation and preparation method thereof | |
CN106134765A (en) | A kind of Ganoderma Folium hydrangeae strigosae Cordyceps mycelium | |
CN1660400A (en) | Medication for improving sleep | |
KR20120053564A (en) | Fermented ginseng with ganoderma lucidum beverage manufacturing method and that beverage | |
CN113521187B (en) | Body resistance strengthening and vitality benefiting paste and preparation method and application thereof | |
CN107893035A (en) | A kind of culture medium of Hericium erinaceus, sealwort bioconversion mycelium, the mycelial extract of sealwort bioconversion and application thereof | |
CN1663606A (en) | Medicine for treating radiation diseases | |
CN106071589A (en) | With Herba Dendrobii juice for a kind of Ganoderma biological drink of carrier preparation | |
CN103230003B (en) | Health food with immunity boosting function and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: XI AN HENGTONG GUANGHUA PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: ZHAO HENG Effective date: 20080411 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20080411 Address after: E building, 17 Yang Road, No. 27, hi tech Zone, Xi'an, Shaanxi Patentee after: Xi'an Hengtong Guanghue Pharmaceutical Co.,Ltd Address before: E building, 17 Yang Road, No. 27, hi tech Zone, Xi'an, Shaanxi Patentee before: Zhao Heng |
|
PP01 | Preservation of patent right |
Effective date of registration: 20081225 Pledge (preservation): Preservation |
|
PD01 | Discharge of preservation of patent |
Date of cancellation: 20091225 Pledge (preservation): Preservation registration |
|
PP01 | Preservation of patent right |
Effective date of registration: 20100611 Granted publication date: 20071128 |
|
PD01 | Discharge of preservation of patent |
Date of cancellation: 20101211 Granted publication date: 20071128 |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20071128 Termination date: 20101219 |